论文部分内容阅读
天津医科大学附属肿瘤医院郝希山教授为首的课题组承担的天津市重点攻关项目——肿瘤治疗新技术研究历时5年刻苦攻关,已取得重大突破。研究应用自体外周血干细胞移植联合大剂量放化疗治疗已被宣判“死刑”的实体瘤患者疗效显著,使72例患者至今全部无病生存。据有关专家预测,这项新技术已有望成为根治性治疗癌症的有效手段之一,为临床医治癌症开辟了新途径。肿瘤治疗新技术研究包括自体外周血干细胞移植治疗实体瘤、基因瘤苗
Tianjin University’s Affiliated Tumor Hospital’s headed by Professor Hao Xishan has undertaken a major breakthrough in the key research project of Tianjin, a key research project for cancer treatment, after five years of painstaking research. Research and application of autologous peripheral blood stem cell transplantation combined with high-dose radiotherapy and chemotherapy for solid tumor patients who have been pronounced “death” has a significant effect, so that 72 patients have survived without disease. According to experts’ predictions, this new technology is expected to be an effective means for radical treatment of cancer, opening up new ways for clinical treatment of cancer. New cancer therapy research includes autologous peripheral blood stem cell transplantation for solid tumors, gene tumor vaccines